Cargando…

Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2

BACKGROUND: Mutations in the genes PRKN and LRRK2 are the most frequent known genetic lesions among Parkinson's disease patients. We have previously reported that in the Portuguese population the LRRK2 c.6055G > A; p.G2019S mutation has one of the highest frequencies in Europe. METHODS: Here...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bras, Jose, Guerreiro, Rita, Ribeiro, Maria, Morgadinho, Ana, Januario, Cristina, Dias, Margarida, Calado, Ana, Semedo, Cristina, Oliveira, Catarina, Hardy, John, Singleton, Andrew
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248204/ https://www.ncbi.nlm.nih.gov/pubmed/18211709 http://dx.doi.org/10.1186/1471-2377-8-1

Ejemplares similares

Analysis of Nigerians with Apparently Sporadic Parkinson Disease for Mutations in LRRK2, PRKN and ATXN3
por: Okubadejo, Njideka, et al.
Publicado: (2008)

Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
por: Oczkowska, Anna, et al.
Publicado: (2013)

Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort
por: Guerreiro, Rita J, et al.
Publicado: (2006)

Systematic Functional Analysis of PINK1 and PRKN Coding Variants
por: Broadway, Benjamin J., et al.
Publicado: (2022)

Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism
por: Borsche, Max, et al.
Publicado: (2020)

Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update
por: Nuytemans, Karen, et al.
Publicado: (2010)

Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson’s disease
por: Trinh, Joanne, et al.
Publicado: (2022)

Rare and novel variants of PRKN and PINK1 genes in Vietnamese patients with early‐onset Parkinson’s disease
por: Ton, Nguyen Dang, et al.
Publicado: (2020)

Exon Dosage Variations in Brazilian Patients with Parkinson’s Disease: Analysis of SNCA, PARKIN, PINK1 and DJ-1 Genes
por: Moura, Karla Cristina Vasconcelos, et al.
Publicado: (2012)

Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent
por: Hou, Xu, et al.
Publicado: (2023)

Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese population
por: Yu, Wen-Juan, et al.
Publicado: (2015)

SNCA-AS1 in aging and Parkinson’s disease
por: Carelli, Stephana, et al.
Publicado: (2022)

Assessing the relationship between monoallelic PRKN mutations and Parkinson’s risk
por: Lubbe, Steven J, et al.
Publicado: (2021)

Investigation of PRKN Mutations in Levodopa-Induced Dyskinesia in Parkinson’s Disease Treatment
por: Bispo, Ana Gabrielle, et al.
Publicado: (2023)

Comment on “mt-Keima detects PINK1-PRKN mitophagy in vivo with greater sensitivity than mito-QC”
por: Ganley, Ian G., et al.
Publicado: (2021)

Analysis of LRRK2, SNCA, and ITGA8 Gene Variants with Sporadic Parkinson's Disease Susceptibility in Chinese Han Population
por: Fang, Jie, et al.
Publicado: (2016)

Mitochondrial Dysfunction in Dopaminergic Neurons Derived from Patients with LRRK2- and SNCA-Associated Genetic Forms of Parkinson’s Disease
por: Vetchinova, Anna S., et al.
Publicado: (2023)

Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression
por: Gispert, Suzana, et al.
Publicado: (2015)

LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1
por: Azkona, Garikoitz, et al.
Publicado: (2016)

The SNCA-Rep1 Polymorphic Locus: Association with the Risk of Parkinson’s Disease and SNCA Gene Methylation
por: Iakovenko, E. V., et al.
Publicado: (2020)

Analysis of PRKN Variants and Clinical Features in Polish Patients with Parkinson’s Disease
por: Oczkowska, Anna, et al.
Publicado: (2015)

A homozygous PRKN-associated juvenile Parkinson's disease with pregnancy in China
por: Li, Hong-xing, et al.
Publicado: (2023)

Molecular characterization of Dirofilaria spp. circulating in Portugal
por: Ferreira, Cátia, et al.
Publicado: (2017)

Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism
por: Lucchini, Roberto G., et al.
Publicado: (2020)

GAK and PRKCD are positive regulators of PRKN-independent mitophagy
por: Munson, Michael J., et al.
Publicado: (2021)

Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations
por: Guerreiro, Rita, et al.
Publicado: (2014)

Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
por: Luo, Ningdi, et al.
Publicado: (2019)

Methyl-Arginine Profile of Brain from Aged PINK1-KO+A53T-SNCA Mice Suggests Altered Mitochondrial Biogenesis
por: Auburger, Georg, et al.
Publicado: (2016)

Long-read sequencing resolves a complex structural variant in PRKN Parkinson’s disease
por: Daida, Kensuke, et al.
Publicado: (2023)

Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies
por: Bras, Jose, et al.
Publicado: (2014)

Burden and severity of children's hospitalizations by respiratory syncytial virus in Portugal, 2015–2018
por: Bandeira, Teresa, et al.
Publicado: (2022)

A population scale analysis of rare SNCA variation in the UK Biobank
por: Blauwendraat, Cornelis, et al.
Publicado: (2020)

Maackiain Ameliorates 6-Hydroxydopamine and SNCA Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson’s Disease in Caenorhabditis elegans and the SH-SY5Y Cell Line
por: Tsai, Rong-Tzong, et al.
Publicado: (2020)

Fasting Dependent Paroxysmal Exercise Induced Dystonia as Presenting Symptom in PRKN Type of Parkinson's Disease
por: Gattermeyer, Lukas, et al.
Publicado: (2023)

Festination Correlates with SNCA Polymorphism in Chinese Patients with Parkinson's Disease
por: Zheng, Jinhua, et al.
Publicado: (2017)

Genetic Analysis and Literature Review of SNCA Variants in Parkinson's Disease
por: Guo, Yi, et al.
Publicado: (2021)

SNCA 3′ UTR Genetic Variants in Patients with Parkinson’s Disease
por: Blažeković, Antonela, et al.
Publicado: (2021)

SNCA Gene Methylation in Parkinson’s Disease and Multiple System Atrophy
por: Fedotova, Ekaterina Yu., et al.
Publicado: (2023)

Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation
por: Kiely, Aoife P., et al.
Publicado: (2015)

Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson’s Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations
por: Momcilovic, Olga, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0cg98u78f8sjumjdc46s1vdir4